1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ARHGAP33 CTRPv2 pan-cancer AAC 0.21 4e-10
mRNA RFXAP CTRPv2 pan-cancer AAC 0.24 5e-10
mRNA NISCH CTRPv2 pan-cancer AAC 0.22 6e-10
mRNA ILF3 CTRPv2 pan-cancer AAC 0.22 6e-10
mRNA ZNF84 CTRPv2 pan-cancer AAC 0.21 8e-10
mRNA SMARCC1 CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA GPC2 CTRPv2 pan-cancer AAC 0.24 9e-10
mRNA ADNP2 CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA PRPF38A CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA KCNH3 CTRPv2 pan-cancer AAC 0.2 1e-09
Download CSV